MCG Capital Schedules Third Quarter 2013 Earnings Investor

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
MCG Capital Schedules Third Quarter 2013 Earnings Investor Call for October 30, 2013

ARLINGTON, Va., Oct. 28, 2013 (GLOBE NEWSWIRE) -- MCG Capital Corporation (Nasdaq: MCGC ) ("MCG") announced today that it will report third quarter financial results and will discuss MCG's business outlook on Wednesday, October 30, 2013. MCG invites all interested persons to participate in its conference call at 9:00 a.m., Eastern Time. The dial-in number for the call is 877-312-8798. International callers should dial: 253-237-1193. Please dial in at least five minutes prior to the call to register. The call may also be accessed via an audio webcast available on the MCG website at http://investor.mcgcapital.com . Click on the October 30, 2013 Conference Call link to access the call. MCG plans to release its third quarter financial results in advance of the call.

A recording of the call will be available through November 13, 2013. The replay dial-in is 855-859-2056. International callers should dial 404-537-3406. The replay conference ID is 88864898. The replay will also be available via MCG's website.

Conference Call: October 30, 2013 at 9:00 a.m., Eastern Time
Dial-in Number: 877-312-8798 domestic; 253-237-1193 international
Live Webcast/Replay: http://investor.mcgcapital.com
Call Replay: 855-859-2056 domestic; 404-537-3406 international
Replay Conference ID: 88864898

About MCG Capital Corporation

MCG Capital Corporation is a solutions-focused commercial finance company providing capital and advisory services to middle-market companies throughout the United States. Our investment objective is to achieve attractive returns by generating current income and capital gains on our investments. Our capital is generally used by our portfolio companies to finance acquisitions, recapitalizations, buyouts, organic growth, working capital and other general corporate purposes. For more information, please visit www.mcgcapital.com .

Keith Kennedy (703) 247-7513

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Investigation of Stock Transactions: TASK, VBTX, TURN Insights

Updated Category News Views 125

Financial Investigations for Shareholders of TASK, VBTX, and TURN Halper Sadeh LLC is actively investigating several companies regarding potential violations of federal securities laws affecting shareholders. The investigations focus on significant transactions involving TaskUs, Veritex Holdings, and 180 Degree Capital Corp. TaskUs, Inc. and Its Acquisition by Blackstone...

Continue Reading
Comprehensive Analysis of NVIDIA in the Semiconductor Market

Updated Category News Views 678

Understanding NVIDIA's Position in the Semiconductor Sector In today's fast-paced business environment, it is crucial for investors and industry followers to conduct in-depth analyses of key companies. This article offers a detailed comparison of NVIDIA (NASDAQ: NVDA) with its main competitors in the Semiconductors & Semiconductor Equipment sector. By looking at important...

Continue Reading
Invivyd Set to Showcase PEMGARDA™ Findings at Upcoming Event

Updated Category News Views 54

Invivyd Prepares for IDWeek 2024 Presentations Invivyd, Inc. (NASDAQ: IVVD) is an innovative biopharmaceutical company focusing on creating solutions for serious viral infections. As they gear up for their participation in IDWeek 2024, they will be unveiling exciting new data concerning their investigational monoclonal antibody, PEMGARDA™ (pemivibart). The conference is...

Continue Reading
The Rising Stars: Growth Potential of Key Investments

Updated Category News Views 95

Carnival made waves post-pandemic as it clawed its way back from meme stock purgatory. Traders watched the cruise line stumble but now see flickers of recovery amidst hefty debt burdens that peaked around $35 billion. Sure, they pulled in a whopping $1.7 billion net income in the last quarter, but those profit forecasts? All over the place—talk about a mixed bag. And...

Continue Reading
PharmAla Partners with Logistics Expert for Clinical Trials

Updated Category News Views 114

PharmAla Forms Strategic Alliance for Enhanced US Distribution PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a dedicated biotechnology company, is excited to share its latest strategic move aimed at improving service delivery in the United States. The company has engaged a trusted third-party logistics partner, specialized...

Continue Reading